脓毒症治疗系统评价的方法学质量:一项横断面研究
该横断面研究检索MEDLINE、EMBASE和Cochrane数据库,纳入2018至2023年发表的102篇针对脓毒症治疗随机对照试验、且至少包含一项Meta分析的系统评价,使用AMSTAR 2工具评价其方法学质量,并用逻辑回归探索文献特征与质量评级的关联。结果显示,仅2篇(2.0%)总体质量高,4篇(3.9%)中等,7篇(6.9%)低,89篇(87.3%)极低;关键方法学领域表现差:仅32篇(31.4%)在结果解读中考虑原始研究偏倚风险,22篇(21.6%)解释排除的原始研究,16篇(15.7%)应用全面检索策略。发表在较高影响因子期刊上的系统评价与更高质量相关(调整OR 1.19,95%CI 1.05至1.36)。作者认为,近期脓毒症治疗系统评价的方法学质量不令人满意,未来评价者应解决上述关键方法学问题,并应分配更多资源支持医疗专业人员和其他证据使用者的批判性评价持续培训。
要点
- 102篇脓毒症治疗系统评价中,仅2篇(2.0%)AMSTAR 2总体质量高,89篇(87.3%)为极低质量。
- 关键方法学缺陷:仅32篇(31.4%)在结果解读中考虑原始研究偏倚风险,22篇(21.6%)解释排除的原始研究,16篇(15.7%)应用全面检索策略。
- 发表在较高影响因子期刊上的系统评价与更高质量相关(调整OR 1.19,95%CI 1.05至1.36)。
- 作者认为,近期脓毒症治疗系统评价的方法学质量不令人满意,未来评价者应解决上述关键方法学问题。
- 作者建议,应分配更多资源支持医疗专业人员和其他证据使用者的批判性评价持续培训。
适用人群与场景
- 2018至2023年发表的、针对脓毒症治疗随机对照试验且至少包含一项Meta分析的系统评价。
诊断标准与关键阈值
- 使用AMSTAR 2工具评价系统评价的方法学质量,总体质量分级为高、中、低、极低。
研究设计与关键结果
- 研究类型:横断面研究,纳入102篇系统评价。
- 总体质量:高2篇(2.0%),中等4篇(3.9%),低7篇(6.9%),极低89篇(87.3%)。
- 关键方法学领域:仅32篇(31.4%)在结果解读中考虑原始研究偏倚风险,22篇(21.6%)解释排除的原始研究,16篇(15.7%)应用全面检索策略。
- 发表在较高影响因子期刊上的系统评价与更高质量相关:调整OR 1.19(95%CI 1.05至1.36)。
证据类型、等级与局限
- 证据类型:横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,近期脓毒症治疗系统评价的方法学质量不令人满意,未来评价者应解决上述关键方法学问题。
- 作者建议,应分配更多资源支持医疗专业人员和其他证据使用者的批判性评价持续培训。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Systematic reviews (SRs) offer updated evidence to support decision-making on sepsis treatments. However, the rigour of SRs may vary, and methodological flaws may limit their validity in guiding clinical practice. This cross-sectional study appraised the methodological quality of SRs on sepsis treatments.
METHODS: We searched MEDLINE, EMBASE, and Cochrane Database for eligible SRs on randomised controlled trials on sepsis treatments with at least one meta-analysis published between 2018 and 2023. We extracted SRs' bibliographical characteristics with a pre-designed form and appraised their methodological quality using AMSTAR (A MeaSurement Tool to Assess systematic Reviews) 2. We applied logistic regressions to explore associations between bibliographical characteristics and methodological quality ratings.
RESULTS: Among the 102 SRs, two (2.0%) had high overall quality, while respectively four (3.9%), seven (6.9%) and 89 (87.3%) were of moderate, low, and critically low quality. Performance in several critical methodological domains was poor, with only 32 (31.4%) considering the risk of bias in primary studies in result interpretation, 22 (21.6%) explaining excluded primary studies, and 16 (15.7%) applying comprehensive searching strategies. SRs published in higher impact factor journals (adjusted odds ratio: 1.19; 95% confidence interval: 1.05 to 1.36) was associated with higher methodological quality.
CONCLUSIONS: The methodological quality of recent SRs on sepsis treatments is unsatisfactory. Future reviewers should address the above critical methodological aspects. More resources should also be allocated to support continuous training in critical appraisal among healthcare professionals and other evidence users.
参考来源
- Ho L, Chen X, Kwok YL, et al. Methodological quality of systematic reviews on sepsis treatments: A cross-sectional study. Am J Emerg Med. 2023. PMID: 38096636. doi:10.1016/j.ajem.2023.12.001
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。